Amgen Inc.
GB ˙ BATS-CHIXE ˙ NL0000888691
SecurityGB:AMGD / Amgen Inc.
InstitutionFmb Wealth Management
Latest Disclosed Ownership6,434 shares
Latest Disclosed Value $ 2,263,642
Fmb Wealth Management reports 8.39% decrease in ownership of AMGD / Amgen Inc.

On April 15, 2026 - Fmb Wealth Management filed a 13F-HR form disclosing ownership of 6,434 shares of Amgen Inc. (GB:AMGD) valued at $2,263,642 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 7,023 shares of Amgen Inc.. This represents a change in shares of -8.39% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F AMGEN COM 031162100 6,434 -589 -8.39 2,264 -1.52 0.8692
2026-01-22 2025-12-31 13F AMGEN COM 031162100 7,023 24 0.34 2,299 16.41 0.8399
2025-10-15 2025-09-30 13F AMGEN COM 031162100 6,999 -27 -0.38 1,975 0.66 0.8365
2025-07-18 2025-06-30 13F AMGEN COM 031162100 7,026 -121 -1.69 1,962 -11.90 0.9340
2025-04-15 2025-03-31 13F AMGEN COM 031162100 7,147 71 1.00 2,227 20.72 1.2318
2025-01-29 2024-12-31 13F AMGEN COM 031162100 7,076 -30 -0.42 1,844 -19.44 1.0386
2024-11-04 2024-09-30 13F AMGEN COM 031162100 7,106 -60 -0.84 2,289 2.28 1.2939
2024-11-04 2024-06-30 13F AMGEN COM 031162100 7,166 -6 -0.08 2,239 9.76 1.7024
2024-11-04 2024-03-31 13F AMGEN COM 031162100 7,172 4 0.06 2,039 -1.21 1.6266
2024-10-15 2023-12-31 13F AMGEN COM 031162100 7,168 0 0.00 2,064 7.17 1.8863
2024-10-15 2023-09-30 13F AMGEN COM 031162100 7,168 -1 -0.01 1,926 21.06 2.0678
2024-10-15 2023-06-30 13F AMGEN COM 031162100 7,169 3,438 92.15 1,592 76.58 1.6899
2024-10-15 2023-03-31 13F AMGEN COM 031162100 3,731 -6 -0.16 902 -8.15 1.0762
2024-10-15 2022-12-31 13F AMGEN COM 031162100 3,737 3,737 981 1.2635
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.